In Vitro Bactericidal Activity of Trimethoprim-Sulfamethoxazole/Colistin Combination Against Carbapenem-Resistant Klebsiella pneumoniae Clinical Isolates

被引：12
|
作者：
Su, Jiachun [1 ,2 ]
Li, Dan [1 ,2 ]
Guo, Qinglan [1 ,2 ]
Guo, Yan [1 ,2 ]
Zheng, Yonggui [1 ,2 ]
Xu, Xiaogang [1 ,2 ,3 ]
机构：
[1] Fudan Univ, Huashan Hosp, Inst Antibiot, 12 Middle Wulumuqi Rd, Shanghai 200040, Peoples R China
[2] Natl Hlth & Family Planning Commiss, Key Lab Clin Pharmacol Antibiot, Shanghai, Peoples R China
[3] Fudan Univ, Huashan Hosp, Natl Clin Res Ctr Aging & Med, Shanghai, Peoples R China
来源：
MICROBIAL DRUG RESISTANCE | 2019年 / 25卷 / 02期
关键词：
carbapenem-resistant Klebsiella pneumoniae; trimethoprim-sulfamethoxazole; colistin; bactericidal activity; COLISTIN; THERAPY;
D O I：
10.1089/mdr.2018.0085
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
Carbapenem-resistant Klebsiella pneumoniae (CRKP) has emerged as a formidable health challenge in recent years owing to the shortage of effective antibiotics. Colistin is the last and sometimes the only therapeutic option for CRKP infections. Unfortunately, resistance to colistin monotherapy is likely to develop. CRKP in China reportedly exhibit low rates of resistance to trimethoprim-sulfamethoxazole. The aim of this study was to evaluate the in vitro efficacy of trimethoprim-sulfamethoxazole in combination with colistin against four CRKP clinical isolates. The trimethoprim-sulfamethoxazole/colistin combination rapidly killed all four of the tested isolates after 2 h up to 24 h. Trimethoprim-sulfamethoxazole is one of the few remaining antimicrobials with some activity against CRKP. In particular, combined with colistin, trimethoprim-sulfamethoxazole might be promising for the treatment of CRKP infections.
引用
收藏
页码：152 / 156
页数：5
相关论文
共 50 条
  • [21] A Case of Sepsis Due to Carbapenem-Resistant Klebsiella pneumoniae in an Extremely Low-Birth Weight Infant Treated with Trimethoprim-Sulfamethoxazole
    Weng, Bowen
    Zhang, Xiaoyue
    Hong, Wenchao
    Yan, Chongbing
    Gong, Xiaohui
    Cai, Cheng
    INFECTION AND DRUG RESISTANCE, 2021, 14 : 2321 - 2325
  • [22] Analysis of colistin resistance in carbapenem-resistant Enterobacterales and XDR Klebsiella pneumoniae
    Bir, Raunak
    Gautam, Hitender
    Arif, Nazneen
    Chakravarti, Priyanka
    Verma, Jyoti
    Banerjee, Sayantan
    Tyagi, Sonu
    Mohapatra, Sarita
    Sood, Seema
    Dhawan, Benu
    Chaudhry, Rama
    Kapil, Arti
    Das, Bimal Kumar
    Das, Bhabatosh
    THERAPEUTIC ADVANCES IN INFECTIOUS DISEASE, 2022, 9
  • [23] Flow Cytometry as a Rapid and Valuable Method in Investigation of Colistin Resistance in Carbapenem-Resistant Klebsiella pneumoniae Isolates
    Ucak, Safak Ceren
    Ongen, Betigul
    ANTIBIOTICS-BASEL, 2024, 13 (05):
  • [24] Analysis of colistin resistance in carbapenem-resistant Enterobacterales and XDR Klebsiella pneumoniae
    Bir, Raunak
    Gautam, Hitender
    Arif, Nazneen
    Chakravarti, Priyanka
    Verma, Jyoti
    Banerjee, Sayantan
    Tyagi, Sonu
    Mohapatra, Sarita
    Sood, Seema
    Dhawan, Benu
    Chaudhry, Rama
    Kapil, Arti
    Das, Bimal Kumar
    Das, Bhabatosh
    THERAPEUTIC ADVANCES IN INFECTIOUS DISEASE, 2022, 9
  • [25] Colistin resistance in carbapenem-resistant Klebsiella pneumoniae isolates from a pediatric hospital from Corrientes, Argentina
    Leandro Pellegrini, Juan
    Aguirre, Clarisa
    Marina Soto, Susana
    Ramona Lovera, Laura Marcela
    Silvina Losch, Liliana
    Alejandro Di Conza, Jose
    Antonio Merino, Luis
    REVISTA CHILENA DE INFECTOLOGIA, 2022, 39 (02): : 109 - 116
  • [26] Trimethoprim-sulfamethoxazole vs. colistin or ampicillin-sulbactam for the treatment of carbapenem-resistant Acinetobacter baumannii: A retrospective matched cohort study
    Raz-Pasteur, Ayelet
    Liron, Yael
    Amir-Ronen, Reut
    Abdelgani, Siham
    Ohanyan, Astghik
    Geffen, Yuval
    Paul, Mical
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2019, 17 : 168 - 172
  • [27] Risk Factors for Colistin-Resistant Carbapenem-Resistant Klebsiella pneumoniae in the Postacute Care Setting
    Zhang, Helen L.
    Han, Jennifer H.
    Lapp, Zena
    Snitkin, Evan
    Goldstein, Ellie J. C.
    Muldoon, Sean
    Tolomeo, Pam
    Lautenbach, Ebbing
    OPEN FORUM INFECTIOUS DISEASES, 2022, 9 (09):
  • [28] Carbapenem-resistant Klebsiella pneumoniae sepsis in corticosteroid receipt mice: tigecycline or colistin monotherapy versus tigecycline/colistin combination
    Demiraslan, Hayati
    Dinc, Gokcen
    Ahmed, Salman Shaheer
    Elmali, Ferhan
    Metan, Gokhan
    Alp, Emine
    Doganay, Mehmet
    JOURNAL OF CHEMOTHERAPY, 2014, 26 (05) : 276 - 281
  • [29] Carbapenem-resistant Klebsiella pneumoniae endocarditis in a young adult Successful treatment with gentamicin and colistin
    Benenson, Shmuel
    Navon-Venezia, Shiri
    Carmeli, Yehuda
    Adler, Amos
    Strahilevitz, Jacob
    Moses, Allon E.
    Block, Colin
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2009, 13 (05) : E295 - E298
  • [30] Amikacin for the treatment of carbapenem-resistant Klebsiella pneumoniae infections: clinical efficacy and toxicity
    Rodrigues, Diogenes
    Baldissera, Giulia Soska
    Mathos, Douglas
    Sartori, Aline
    Zavascki, Alexandre P.
    Rigatto, Maria Helena
    BRAZILIAN JOURNAL OF MICROBIOLOGY, 2021, 52 (04) : 1913 - 1919
12345